Table 1.
Characteristics | Total No. | Status of HT Use at Baseline (Estrogen, Estrogen + Progestin, or User of Mixed Formulations) |
||
Baseline-Never HT User | Baseline-Former HT User | Baseline-Recent HT User | ||
No. of participants | 56,864 | 13,778 | 8,653 | 34,433 |
No. of invasive colon cancer cases | 442 | 151 | 98 | 193 |
Mean age at baseline, years (SD) | 62.7 (9.2) | 65.0 (8.8) | 58.9 (8.5) | |
Menopausal status, %a | ||||
Perimenopausal | 2,235 | 44.7 | 9.9 | 45.3 |
Postmenopausal, natural menopause | 29,397 | 34.7 | 18.3 | 47.0 |
Postmenopausal, bilateral oophorectomy | 8,851 | 4.2 | 12.1 | 83.6 |
Postmenopausal, other reason | 16,381 | 13.5 | 12.0 | 74.5 |
Race/ethnicity, %a | ||||
White | 50,746 | 23.2 | 15.2 | 61.6 |
African American | 1,609 | 38.8 | 19.0 | 42.1 |
Otherb | 4,509 | 30.1 | 14.1 | 55.7 |
Long-term recreational physical activity, %a,c | ||||
Low (<0.5 hour/week of any activity) | 8,920 | 27.0 | 15.7 | 57.3 |
Intermediate | 28,614 | 21.8 | 14.0 | 64.3 |
High (≥3 hours/week of any activity) | 18,963 | 24.4 | 14.4 | 61.3 |
Body mass index, kg/m2a | ||||
<25 | 30,578 | 21.0 | 13.2 | 65.7 |
25–29 | 15,300 | 23.6 | 15.4 | 61.0 |
≥30 | 8,378 | 29.6 | 15.9 | 54.6 |
Regular NSAID usea,d | ||||
Low | 49,058 | 23.9 | 14.3 | 61.9 |
High | 5,944 | 18.8 | 14.8 | 66.4 |
Calcium intake, mga,e | ||||
≤696.8 | 25,944 | 24.1 | 15.5 | 61.4 |
>696.8 | 25,945 | 22.2 | 13.8 | 64.0 |
Calcium, mg, + vitamin D, IU, intakea,f | ||||
Low | 44,377 | 23.5 | 14.2 | 62.3 |
High | 7,512 | 20.8 | 14.0 | 65.3 |
Family history of colorectal cancera,g | ||||
No | 49,073 | 23.3 | 14.2 | 62.5 |
Yes | 6,174 | 24.4 | 16.1 | 59.5 |
Personal history of colorectal polypsa,h | ||||
No | 51,425 | 23.6 | 14.2 | 62.3 |
Yes | 3,822 | 21.0 | 18.1 | 61.0 |
Smoking historya,i | ||||
Never smoker | 33,035 | 24.4 | 14.0 | 61.6 |
Former smoker | 19,878 | 20.9 | 14.8 | 64.3 |
Current smoker | 3,631 | 30.0 | 15.4 | 55.0 |
Alcohol intake, g/daya,j | ||||
0 | 17,520 | 27.9 | 15.4 | 56.7 |
<20 | 31,240 | 21.2 | 13.6 | 65.2 |
≥20 | 5,516 | 22.0 | 14.5 | 63.5 |
Abbreviations: HT, hormone therapy; NSAID, nonsteroidal antiinflammatory drug; SD, standard deviation.
All percentages, except those for race/ethnicity and menopausal status, are age standardized by 5-year age categories to the age distribution of the analytical cohort; the numbers of missing and unknown participants are not shown in the table.
“Other” includes Hispanic, Asian, Native American, mixed, or none reported.
Long-term recreational physical activity combines strenuous and moderate activity and is defined as low, intermediate, or high average weekly hours of long-term recreational physical activity.
Regular NSAID use combines information on aspirin and ibuprofen use. High NSAID use was defined as use ≥4 times per week for more than 4 years; low/no regular NSAID use included all others.
Calcium intake (mg) from diet and supplements was cut at the median value for participants in this analysis, 696.8 mg/day.
Calcium intake plus vitamin D intake (from diet and supplements) was dichotomized as the highest quartile for both calcium and vitamin D versus all others.
A positive family history of colorectal cancer was defined as colon or rectal cancer in at least 1 first-degree relative (mother, father, sister, or brother).
Self-reported personal history of colon or rectal polyps (not cancer) was categorized as no, yes, or unknown.
Smoking history was categorized as never, former, or current smoker.
Alcohol intake was categorized as 0 g/day, <20 g/day, or ≥20 g/day.